We will focus on the development of APIs, custom synthesis and license manufacturing to meet the requirements of the international market and our customers.
以满足市场及客户需求为导向，在非专利原料药和定制合成领域大力发展，开发一系列造福民众的药品。
Our R&D, production and quality system is world-class, all set up according to the ICH and FDA guidelines and fully comply with cGMP.
按照国际一流水平，建设符合ICH及FDA指导原则的科研、生产、质量体系，全面符合cGMP要求。
We are now preparing series of APIs that will come off patent from 2010 to 2015. We are aiming to become one of the best API production base in the world.
瞄准2010－2015年专利到期药品，打造系列医药原料药全球生产基地。
By virtue of our synthetic capabilities, we are working closely with renowned MNCs to develop pharmaceutical intermediates and perform license manufacturing.
发展强大的合成力量，为公司及国际知名医药企业产品开发配套医药中间体，接受客户的定制合成。